1.
Bassi A, Piccolo V, Gallippi G, Argenziano G, Magnano M, Mazzatenta C. Targeting JAK/STAT signaling: ruxolitinib cream in the management of concurrent vitiligo and discoid lupus erythematosus. Dermatol Reports [Internet]. 2025 Sep. 11 [cited 2026 May 25];. Available from: https://journals.pagepress.net/dr/article/view/10458